Fulgent Genetics, Inc. (FLGT) stock
FLGTNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/3047% below fair value
$24.21+0.14 (+0.56%)
Close on Nov 17, 2026Market cap $666.15MP/E –Yield –
Fulgent Genetics total assets
Total assets on the balance sheet at the end of each period.
Fulgent Genetics's total assets was $1.09B at Jun 30, 2026. For fiscal 2025 it was $1.21B, down 0.5% from the year before. Over ten years it grew 70.5% a year on average. The highest annual figure on record is $1.39B in fiscal 2022.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.21B | -0.5% |
| FY2024 | Dec 31, 2024 | $1.22B | -1.2% |
| FY2023 | Dec 31, 2023 | $1.24B | -10.9% |
| FY2022 | Dec 31, 2022 | $1.39B | +8.4% |
| FY2021 | Dec 31, 2021 | $1.28B | +82.6% |
| FY2020 | Dec 31, 2020 | $700.46M | +689.2% |
| FY2019 | Dec 31, 2019 | $88.76M | +64.7% |
| FY2018 | Dec 31, 2018 | $53.90M | -5.7% |
| FY2017 | Dec 31, 2017 | $57.18M | -1.5% |
| FY2016 | Dec 31, 2016 | $58.04M | +895.2% |
| FY2015 | Dec 31, 2015 | $5.83M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $1.09B | -9.2% |
| Q1 FY2026 | Mar 31, 2026 | $1.16B | -4.1% |
| Q4 FY2025 | Dec 31, 2025 | $1.21B | -0.5% |
| Q3 FY2025 | Sep 30, 2025 | $1.21B | -1.6% |
| Q2 FY2025 | Jun 30, 2025 | $1.20B | -2.6% |
| Q1 FY2025 | Mar 31, 2025 | $1.21B | -2.0% |
| Q4 FY2024 | Dec 31, 2024 | $1.22B | -1.2% |
| Q3 FY2024 | Sep 30, 2024 | $1.23B | -9.2% |
| Q2 FY2024 | Jun 30, 2024 | $1.23B | -9.0% |
| Q1 FY2024 | Mar 31, 2024 | $1.23B | -10.7% |
| Q4 FY2023 | Dec 31, 2023 | $1.24B | -10.9% |
| Q3 FY2023 | Sep 30, 2023 | $1.36B | -3.4% |
| Q2 FY2023 | Jun 30, 2023 | $1.35B | -7.3% |
| Q1 FY2023 | Mar 31, 2023 | $1.38B | -6.1% |
| Q4 FY2022 | Dec 31, 2022 | $1.39B | +8.4% |
| Q3 FY2022 | Sep 30, 2022 | $1.41B | +16.7% |
| Q2 FY2022 | Jun 30, 2022 | $1.46B | +39.2% |
| Q1 FY2022 | Mar 31, 2022 | $1.47B | +46.7% |
| Q4 FY2021 | Dec 31, 2021 | $1.28B | +82.6% |
| Q3 FY2021 | Sep 30, 2021 | $1.20B | +387.1% |
| Q2 FY2021 | Jun 30, 2021 | $1.05B | +994.6% |
| Q1 FY2021 | Mar 31, 2021 | $999.08M | +1018.5% |
| Q4 FY2020 | Dec 31, 2020 | $700.46M | +689.2% |
| Q3 FY2020 | Sep 30, 2020 | $247.31M | +304.5% |
| Q2 FY2020 | Jun 30, 2020 | $95.92M | +70.0% |
| Q1 FY2020 | Mar 31, 2020 | $89.33M | +60.5% |
| Q4 FY2019 | Dec 31, 2019 | $88.76M | +64.7% |
| Q3 FY2019 | Sep 30, 2019 | $61.15M | +11.5% |
| Q2 FY2019 | Jun 30, 2019 | $56.44M | +1.6% |
| Q1 FY2019 | Mar 31, 2019 | $55.65M | +0.4% |
| Q4 FY2018 | Dec 31, 2018 | $53.90M | -5.7% |
| Q3 FY2018 | Sep 30, 2018 | $54.85M | -6.5% |
| Q2 FY2018 | Jun 30, 2018 | $55.55M | -5.5% |
| Q1 FY2018 | Mar 31, 2018 | $55.44M | -5.7% |
| Q4 FY2017 | Dec 31, 2017 | $57.18M | -1.5% |
| Q3 FY2017 | Sep 30, 2017 | $58.67M | +157.8% |
| Q2 FY2017 | Jun 30, 2017 | $58.81M | – |
| Q1 FY2017 | Mar 31, 2017 | $58.82M | – |
| Q4 FY2016 | Dec 31, 2016 | $58.04M | – |
| Q3 FY2016 | Sep 30, 2016 | $22.76M | – |
See a number that looks wrong?